Evidence map›Paper›PMID 23074268›Full record

ReviewScience signaling2012

The Hedgehog signal transduction network.

David J Robbins, Dennis Liang Fei, Natalia A Riobo

Abstract readReview
In one paragraph

Review in Science signaling, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 241 papers.

0numbers the graph read from it
0cells of the map it votes in
241citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

241 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Coenzyme Q10 and Intracellular Signalling Pathways: Clinical Relevance.International journal of molecular sciences · 2025
    Review
  6. Review
  7. Review
  8. Review
  9. Synthesis and Evaluation of Aromatic A-Ring 23-Oxavitamin DInternational journal of molecular sciences · 2025
    Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Tai/NCOA2 suppresses the Hedgehog pathway by directly targeting the transcription factor Ci/GLI.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  15. Practical immunomodulatory landscape of glioblastoma multiforme (GBM) therapy.Journal of the Egyptian National Cancer Institute · 2024
    Review
  16. Article
  17. Article
  18. Mechanistic insights into medulloblastoma relapse.Pharmacology & therapeutics · 2024
    Review
  19. Article
  20. Review

181 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

David J RobbinsMolecular Oncology Program, Department of Surgery, Miller School of Medicine, University of Miami, Miami, FL 33136, USA. drobbins@med.miami.edu
Dennis Liang Fei
Natalia A Riobo

Funding

RECONSTITUTION OF HEDGEHOG SIGNALING COMPLEXR01CA082628 · NCI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI ROBBINS, DAVID J · 1999 to 2014
$4.1M
Characterization of Sonic Hedgehog BiogenesisR01GM064011 · NIGMS · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI ROBBINS, DAVID J · 2002 to 2011
$2.6M
Mechanisms of Cell Cycle and Survival Regulation by Hedgehog SignalingR01GM088256 · NIGMS · THOMAS JEFFERSON UNIVERSITY · PI RIOBO-DEL GALDO, NATALIA ANDREA · 2010 to 2014
$1.4M
NCI NIH HHS 5R01CA082628NCI NIH HHS R01 CA082628NIGMS NIH HHS 5R01GM088256NIGMS NIH HHS 5R01GM64011NIGMS NIH HHS R01 GM064011NIGMS NIH HHS R01 GM088256
6 · The paper itself

Abstract

Hedgehog (Hh) proteins regulate the development of a wide range of metazoan embryonic and adult structures, and disruption of Hh signaling pathways results in various human diseases. Here, we provide a comprehensive review of the signaling pathways regulated by Hh, consolidating data from a diverse array of organisms in a variety of scientific disciplines. Similar to the elucidation of many other signaling pathways, our knowledge of Hh signaling developed in a sequential manner centered on its earliest discoveries. Thus, our knowledge of Hh signaling has for the most part focused on elucidating the mechanism by which Hh regulates the Gli family of transcription factors, the so-called "canonical" Hh signaling pathway. However, in the past few years, numerous studies have shown that Hh proteins can also signal through Gli-independent mechanisms collectively referred to as "noncanonical" signaling pathways. Noncanonical Hh signaling is itself subdivided into two distinct signaling modules: (i) those not requiring Smoothened (Smo) and (ii) those downstream of Smo that do not require Gli transcription factors. Thus, Hh signaling is now proposed to occur through a variety of distinct context-dependent signaling modules that have the ability to crosstalk with one another to form an interacting, dynamic Hh signaling network.

Indexed as

Gene Expression RegulationSignal TransductionAnimalsCiliaDevelopmental BiologyDrosophila melanogasterDrosophila ProteinsHedgehog ProteinsHumansModels, BiologicalOncogene ProteinsProteasome Endopeptidase ComplexReceptors, G-Protein-CoupledSmoothened ReceptorTrans-ActivatorsTranscription FactorsDrosophila ProteinsHedgehog ProteinsOncogene ProteinsProteasome Endopeptidase ComplexReceptors, G-Protein-CoupledSmoothened Receptorsmo protein, DrosophilaTrans-ActivatorsTranscription FactorsZinc Finger Protein GLI1

Identifiers

PMID23074268
PMCPMC3705708

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.